--- mi_id: MIPR-node_b65cd53 type: press_release canonical_url: "https://www.pheonixresearch.com/healthcare/healthcare-services/press-release/global-neurofeedback-market/" md_url: "https://www.pheonixresearch.com/healthcare/healthcare-services/press-release/global-neurofeedback-market.md" schema: "@type": NewsArticle "@id": MIPR-node_b65cd53 url: "https://www.pheonixresearch.com/healthcare/healthcare-services/press-release/global-neurofeedback-market/" title: Pheonix Research Publishes 2026 “Global Neurofeedback Market Outlook – Press Release” description: "The global neurofeedback market is projected to grow from USD 1.52 billion in 2025 to USD 3.41 billion by 2033, at a CAGR of 10.6%." datePublished: "2025-10-15T13:51:35+00:00" dateModified: "2026-05-26T10:31:23+00:00" keywords: - Global Neurofeedback Market - Neurofeedback Market Size - Brain Training Market - EEG Neurofeedback Systems - Digital Therapeutics Market - Cognitive Wellness Market - Mental Health Technology Market - Wearable EEG Devices - Neurotherapy Market - Brain-Computer Interface Market - Non-Invasive Brain Therapy - AI Neurofeedback Systems - Cognitive Enhancement Market - Neurotechnology Industry Trends - Neurofeedback Industry Forecast isPartOf: - id: MISG-node_2419cd8 type: CollectionPage url: "https://www.pheonixresearch.com/healthcare/healthcare-services/" name: Healthcare Services - id: MIIN-node_50b4dbf type: CollectionPage url: "https://www.pheonixresearch.com/healthcare/" name: Healthcare - id: MIWS-root type: WebSite url: "https://www.pheonixresearch.com/" name: Pheonix Research acf: phoenix_meta_title: "Global Neurofeedback Market Size, Share & Forecast 2026–2033" phoenix_meta_description: "The global neurofeedback market is projected to grow from USD 1.52 billion in 2025 to USD 3.41 billion by 2033, at a CAGR of 10.6%. " global_schema: organization: "@id": MIWS-root#organization "@type": Organization url: "https://www.pheonixresearch.com/" name: Pheonix Research website: "@id": MIWS-root "@type": WebSite url: "https://www.pheonixresearch.com/" name: Pheonix Research api: "@id": MIWS-root#api "@type": WebAPI url: "https://www.pheonixresearch.com/" graph: node_id: MIPR-node_b65cd53 graph_node_endpoint: "https://graph.statsfocus.com/api/v1/query/live/node/MIPR-node_b65cd53" graph_snapshot: "https://graph.statsfocus.com/api/v1/read/live/graph" graph_exclusions: "https://graph.statsfocus.com/api/v1/read/live/exclusions" graph_meta: "https://graph.statsfocus.com/api/v1/read/live/meta" graph_bundle: "https://graph.statsfocus.com/api/v1/read/live/bundle" discovery: discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json" llms_txt: "https://www.pheonixresearch.com/llms.txt" sitemap: "https://www.pheonixresearch.com/sitemap.xml" --- # Pheonix Research Publishes 2026 “Global Neurofeedback Market Outlook – Press Release” Global Neurofeedback Market to Reach USD 3.41 Billion by 2033, Driven by Rising Mental Health Awareness and AI-Powered Brain Training Technologies May 2026 | Pheonix Research The Global Neurofeedback Market is projected to grow from approximately USD 1.52 billion in 2025 to nearly USD 3.41 billion by 2033, registering a CAGR of around 10.6% during 2026–2033, according to the latest market analysis by Pheonix Research. The market is witnessing significant growth driven by increasing prevalence of neurological and mental health disorders, growing adoption of non-invasive brain training therapies, rising awareness regarding cognitive wellness, and expanding technological advancements in neurodiagnostic and neurotherapeutic systems. Neurofeedback is a non-invasive therapeutic and cognitive training technique that measures brainwave activity and provides real-time feedback to help individuals regulate brain function. It is widely used for the treatment and management of conditions such as ADHD, anxiety, depression, PTSD, epilepsy, sleep disorders, cognitive decline, and stress-related disorders. The market is undergoing rapid transformation through the integration of AI-powered neurofeedback systems, wearable EEG devices, cloud-connected cognitive monitoring platforms, and personalized digital brain training programs. A major factor supporting market growth is the rising global burden of mental health and neurological disorders. The increasing incidence of anxiety, depression, ADHD, insomnia, and cognitive disorders is driving demand for alternative, drug-free therapeutic interventions. The growing preference for non-pharmacological therapies is further accelerating adoption. Patients and healthcare providers are increasingly seeking safe, personalized, and side-effect-free treatment options for mental and neurological health management. Technological advancements in wearable EEG systems and portable neurofeedback devices are significantly expanding accessibility. Home-based neurofeedback solutions are enabling convenient cognitive training and therapeutic monitoring beyond clinical environments. Increasing public awareness regarding cognitive wellness and brain optimization is also creating strong market opportunities. Neurofeedback is gaining traction across corporate wellness programs, sports performance enhancement, educational support, and preventive mental healthcare. The integration of artificial intelligence and digital therapeutics is further reshaping the market landscape. AI-powered adaptive algorithms are improving signal interpretation, therapy personalization, and treatment optimization. North America continues to dominate the global market due to advanced neurotechnology adoption and strong mental healthcare infrastructure, while Asia-Pacific is emerging as the fastest-growing region supported by expanding healthcare access and rising mental health awareness. Key players operating in the market include BrainMaster Technologies Inc., NeuroCare Group AG, Thought Technology Ltd., EEG Info, Mind Media B.V., Brain Scientific Inc., Neuroelectrics, Wearable Sensing, Inc., Muse (InteraXon), and Mitsar Co. Ltd., all focusing on AI-driven innovation, wearable neurotechnology, and personalized therapeutic platforms. A senior market analyst at Pheonix Research stated: “The neurofeedback market is entering a transformative phase as digital neurotechnology and AI-powered brain training solutions become increasingly integrated into mental healthcare. Personalized, accessible, and clinically validated neurofeedback systems are expected to unlock significant long-term growth opportunities.” Key Market Highlights Rising prevalence of neurological and mental health disorders globally Growing demand for non-pharmacological brain health therapies Increasing adoption of wearable EEG and home-based neurofeedback systems Rapid integration of AI-powered adaptive therapy platforms Expanding applications in cognitive enhancement and wellness optimization Strong growth opportunities through digital therapeutics integration The market is also witnessing increasing investments in cloud-based analytics, real-time brain mapping, virtual therapeutic ecosystems, and personalized cognitive optimization platforms. Post-2025, the industry is expected to benefit from stronger adoption of AI-driven adaptive neurofeedback, virtual reality-assisted brain training, remote therapeutic ecosystems, and preventive digital mental wellness solutions. Organizations investing in clinically validated neurotechnology platforms, intelligent therapeutic algorithms, and consumer-accessible wearable systems are expected to strengthen their competitive positioning in the evolving global neurofeedback market. 📊 For detailed insights and full report access, visit:👉https://www.pheonixresearch.com/healthcare/healthcare-services/market-report/global-neurofeedback-market/ About Pheonix Research Pheonix Research is a global market intelligence and strategic advisory firm delivering data-driven insights across healthcare technology, neurotechnology, digital therapeutics, mental wellness innovation, and emerging healthcare transformation sectors. Through advanced analytics and forecasting frameworks, Pheonix Research enables organizations to identify growth opportunities and strengthen long-term strategic decision-making. Media Contact Pheonix ResearchEmail: media@pheonixresearch.comWebsite: www.pheonixresearch.com